You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Dow
Harvard Business School
Mallinckrodt
Boehringer Ingelheim

Last Updated: March 31, 2020

DrugPatentWatch Database Preview

Litigation Details for ACTELION PHARMACEUTICALS LTD. v. SUN PHARMACEUTICAL INDUSTRIES, INC. (D.N.J. 2017)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

ACTELION PHARMACEUTICALS LTD. v. SUN PHARMACEUTICAL INDUSTRIES, INC. (D.N.J. 2017)

Docket   Start Trial Date Filed 2017-07-07
Court District Court, D. New Jersey Date Terminated 2019-08-21
Cause 15:1126 Patent Infringement Assigned To Peter G. Sheridan
Jury Demand None Referred To Douglas E. Arpert
Parties ACTELION PHARMACEUTICALS LTD.; SUN PHARMACEUTICAL INDUSTRIES LIMITED; SUN PHARMACEUTICAL INDUSTRIES, INC.
Patents 4,335,139; 8,318,802; 8,598,227
Attorneys ANGELA CHERYL NI; CHARLES MICHAEL LIZZA; DAVID LEIGH MOSES; GREGORY D. MILLER; JAMES S. RICHTER; SAMUEL SEHO PARK; SARAH ANN SULLIVAN; SUN PHARMACEUTICAL INDUSTRIES, INC.; WILLIAM C. BATON
Firms Midlige Richter LLC; Paul Hastings LLP; Rivkin Radler LLP; Saul Ewing Arnstein & Lehr LLP; Winston & Strawn; Winston and Strawn LLP
Link to Docket External link to docket
Small Molecule Drugs cited in ACTELION PHARMACEUTICALS LTD. v. SUN PHARMACEUTICAL INDUSTRIES, INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for ACTELION PHARMACEUTICALS LTD. v. SUN PHARMACEUTICAL INDUSTRIES, INC. (D.N.J. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 66 United States Patent, which ultimately issued as U.S. Patent No. 4,335,139 (“the Watts Patent”). (See Declaration…Harold Deci.), Ex. I, United States Patent No. 4,335,139). The Watts patent claims: …concerning United States Patent No. 8,598,227 (“227 patent”). The ‘227 patent is listed to market and …‘227 patent — in the ‘227 patent and its prosecution history, the ‘802 divisional patent and its…36 (Sept. 30, 2004); Ex. 1, U.S. Patent Number 8,598,227 (“227 Patent”)). Flolan consists of “epoprostenol External link to document
0000-00-00 73 Order of Dismissal infringement of United States Patent No. 8,598,227 ("the '227 patent"); Case 3:17-cv-05015…expiration of the '227 Patent, including any patent term extensions and/or patent term adjustments and…expiration of the '227 Patent was a technical act of patent infringement with respect to one…AND ORDER WHEREAS, this action for patent infringement ("the Litigation") was brought…certification" with respect to the '227 patent and seeking approval to engage in the commercial External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
AstraZeneca
Dow
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.